Review: Lessons Learned From Clinical Trials Using Antimicrobial Peptides (AMPs)

Related Experiment Video

Updated: Sep 21, 2026

Development of a Backbone Cyclic Peptide Library as Potential Antiparasitic Therapeutics Using Microwave Irradiation
08:48

Development of a Backbone Cyclic Peptide Library as Potential Antiparasitic Therapeutics Using Microwave Irradiation

Published on: January 26, 2016

12.1K

Gabrielle S Dijksteel1,2, Magda M W Ulrich1,2,3, Esther Middelkoop1,2

  • 1Association of Dutch Burn Centres, Beverwijk, Netherlands.

Frontiers in Microbiology
|March 11, 2021
PubMed

Insights

Antimicrobial peptides (AMPs) show potential as antibiotic alternatives due to their membrane-disrupting action, which limits bacterial resistance. This review explores AMPs

Area of Science:

  • Microbiology and Immunology
  • Drug Discovery and Development

Background:

  • Antimicrobial peptides (AMPs), also known as host defense peptides, are crucial components of the innate immune system.
  • AMPs exhibit broad-spectrum activity against bacteria, fungi, viruses, and yeast, and possess immunomodulatory functions.
  • Their non-specific membrane-disrupting mechanism of action is associated with a low propensity for inducing microbial resistance.

Purpose of the Study:

  • To review the potential of AMPs as novel therapeutic agents against the rising threat of antibiotic-resistant bacteria.
  • To identify and discuss the key challenges hindering the clinical translation and implementation of AMP-based therapies.
  • To propose strategies for enhancing the success rate of AMPs in clinical trials, drawing insights from past experiences.

Main Methods:

  • Literature review of existing research on antimicrobial peptides, their mechanisms of action, and clinical trial data.
  • Analysis of factors contributing to the limited clinical success of AMPs to date.
  • Synthesis of strategies to overcome translational barriers for AMPs.

Main Results:

  • AMPs demonstrate significant potential as alternatives to conventional antibiotics due to their unique mechanism of action.
  • Several challenges, including toxicity, stability, and formulation, impede the clinical progression of AMPs.
  • Lessons learned from clinical trials highlight the need for optimized delivery systems and targeted therapeutic applications.

Conclusions:

  • Antimicrobial peptides represent a promising frontier in combating antimicrobial resistance, offering a distinct advantage over traditional antibiotics.
  • Addressing the identified challenges through innovative strategies is essential for realizing the full therapeutic potential of AMPs.
  • Further research and carefully designed clinical trials are necessary to establish AMPs as a viable clinical treatment option.
Keywords:
antimicrobial peptideclinical trialcytotoxicityimprovement strategiesinfectionmechanism of actionpeptide modificationsresistance

More Related Videos

Antimicrobial Peptides Produced by Selective Pressure Incorporation of Non-canonical Amino Acids11:56

Antimicrobial Peptides Produced by Selective Pressure Incorporation of Non-canonical Amino Acids

Published on: May 4, 2018

12.8K
Antimicrobial Characterization of Advanced Materials for Bioengineering Applications08:08

Antimicrobial Characterization of Advanced Materials for Bioengineering Applications

Published on: August 4, 2018

22.5K

Related Concept Videos

Surface Membrane Barriers01:18

Surface Membrane Barriers

The skin and mucous membranes serve as the primary line of defense against pathogens by providing both physical and chemical protection. These barriers are essential in preventing the entry and establishment of microbes, thereby maintaining the integrity of the host.
The outer layer of the skin, the epidermis, is a robust barrier comprising layers of closely packed keratinized cells. This dense arrangement prevents microbes from penetrating the body. The periodic shedding of epidermal cells...
Antimicrobial Proteins01:23

Antimicrobial Proteins

Antimicrobial proteins are important components of the immune system. They aid the body in combating pathogens by either killing them directly or hindering their replication processes. Four main types of antimicrobial substances are interferons, the complement system, iron-binding proteins, and antimicrobial proteins.
Interferons
Interferons (IFNs) are proteins produced by lymphocytes, macrophages, and fibroblasts infected with viruses. While IFNs cannot prevent viruses from entering and...
Microorganisms in Medicine and Therapeutics01:29

Microorganisms in Medicine and Therapeutics

Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.
Antimicrobial Effectiveness01:28

Antimicrobial Effectiveness

The effectiveness of antimicrobial agents depends on various factors influencing their ability to eliminate microbial populations. Larger microbial populations require more time for complete eradication, emphasizing the importance of population size analysis when evaluating antimicrobial efficacy.Microbial resistance to antimicrobial agents varies significantly. Highly resilient microorganisms include endospores, gram-negative bacteria, and non-enveloped viruses, while prions are exceptionally...
Inhibitors of Bacterial Protein Synthesis01:25

Inhibitors of Bacterial Protein Synthesis

Aminoglycosides constitute a highly potent class of bactericidal antibiotics that exert their antimicrobial effects by targeting the bacterial ribosome, specifically disrupting protein synthesis. These polycationic molecules consist of amino-modified sugars linked via glycosidic bonds to an aminocyclitol core such as 2-deoxystreptamine or streptamine. Their strong positive charges facilitate tight binding to the negatively charged phosphate backbone of ribosomal RNA (rRNA), primarily at the 16S...
Clinical Significance of Antibiotic Resistance01:25

Clinical Significance of Antibiotic Resistance

Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within the One...